UniSuper Management Pty Ltd Increases Stock Position in Cardinal Health, Inc. $CAH

UniSuper Management Pty Ltd raised its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 30.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 28,375 shares of the company’s stock after purchasing an additional 6,559 shares during the period. UniSuper Management Pty Ltd’s holdings in Cardinal Health were worth $4,454,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Norges Bank purchased a new stake in shares of Cardinal Health during the second quarter valued at $584,420,000. Acadian Asset Management LLC lifted its stake in Cardinal Health by 92.5% during the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock valued at $282,063,000 after acquiring an additional 807,063 shares during the period. Prudential Financial Inc. boosted its holdings in shares of Cardinal Health by 476.8% during the 2nd quarter. Prudential Financial Inc. now owns 883,348 shares of the company’s stock valued at $148,402,000 after acquiring an additional 730,209 shares during the last quarter. Voya Investment Management LLC boosted its holdings in shares of Cardinal Health by 298.3% during the 3rd quarter. Voya Investment Management LLC now owns 821,723 shares of the company’s stock valued at $128,978,000 after acquiring an additional 615,398 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC bought a new stake in shares of Cardinal Health in the second quarter worth approximately $79,963,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

NYSE:CAH opened at $208.29 on Monday. Cardinal Health, Inc. has a one year low of $120.72 and a one year high of $215.48. The business has a fifty day moving average price of $205.78 and a 200-day moving average price of $176.35. The firm has a market capitalization of $49.49 billion, a price-to-earnings ratio of 31.42, a price-to-earnings-growth ratio of 1.41 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The company had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same period in the previous year, the business earned $1.88 earnings per share. Cardinal Health’s quarterly revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Investors of record on Friday, January 2nd were paid a dividend of $0.5107 per share. The ex-dividend date was Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s payout ratio is 30.77%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on CAH shares. Citigroup upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and increased their price objective for the company from $190.00 to $244.00 in a research report on Friday, January 9th. Leerink Partners set a $240.00 price target on Cardinal Health in a report on Tuesday, January 13th. Argus lifted their price objective on Cardinal Health from $211.00 to $232.00 and gave the stock a “buy” rating in a report on Friday. Wells Fargo & Company upped their price objective on Cardinal Health from $221.00 to $237.00 and gave the company an “overweight” rating in a research report on Thursday, January 15th. Finally, UBS Group increased their target price on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a report on Friday, October 31st. Fourteen research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $221.07.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.